• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » 3M to lay off another 2,900 in $300M restructuring

3M to lay off another 2,900 in $300M restructuring

December 3, 2020 By Nancy Crotti

3M3M (NYSE:MMM) announced today that it will lay off an additional 2,900 workers in an ongoing restructuring that will cost the company up to $300 million.

The Maplewood, Minn.-based manufacturing conglomerate said the cuts would span across its businesses and geographies, resulting in a total pre-tax charge of $250 million to $300 million — including $120 million to $150 million in the fourth quarter of 2020.

3M said it expects to take the remainder of the pre-tax charge primarily in the second half of 2021. The move could yield annual pre-tax savings of $200 million to $250 million, including $75 million to $100 million in 2021.

The company said in a statement that the cuts will put it in a better position to “take advantage of global market trends in e-commerce, personal safety, health care, automotive electrification, and home improvement. At the same time, the company plans to de-prioritize investments in end markets where growth is slower.”

3M did not identify those markets. Total sales for the month of October were down -4% in transportation and electronics; that segment’s revenues dropped by -7.4% for the third quarter, which ended Sept. 30, 2020, and by -11.2% for the first nine months of 2020, according to the company’s Q3 results.

The company has been a major producer of personal protective equipment during the COVID-19 pandemic, especially the highly sought-after N95 respirator mask. But 3M makes far more than just PPE, which means the overall business has faced pandemic-related challenges. Q3 total sales increased 8.1% in healthcare, 6.9% in safety and industrial, and 5.5% in consumer products, the company reported.

3M laid off 1,700 workers during its second-quarter — with many of the jobs related to the company’s divested drug delivery business. It then cut another 400 jobs to rein in expenses amid the COVID-19 pandemic.

CEO Mike Roman cited global economic shifts due to the pandemic as the reason for cuts announced today.

“The COVID-19 pandemic has advanced the pace of change and disrupted end markets around the world, increasing the need for companies to adapt faster,” Roman said in a news release. “At the same time, we are seeing significant opportunities from our new operating model which we launched at the start of the year. As a result, we are taking further actions to streamline our operations, positioning us to deliver greater growth and productivity as global markets emerge from the pandemic.”

3M launched the new global operating model in January. Today’s actions will eliminate redundancies and better use analytics to drive additional efficiencies, according to the company. In marketing, 3M said it will build on its success in using data insights, accelerating global marketing programs and starting digital engagements with customers.

3M had 96,000 employees globally at the end of 2019, according to its most recent annual report.

Shares in MMM shares opened at $171.04 and peaked around midday at $173.39, up 1.4%.

Assistant editor Sean Whooley contributed to this report.

 

 

 

 

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: 3m, 3M Drug Delivery Systems, coronavirus, covid

More recent news

  • Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure
  • Autonomix taps former Medtronic FDA counsel head for board of directors
  • Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say
  • Science Corp. names president as it looks to roll out vision-restoring implant
  • Mindray looks to fill hospital ventilator gap left by Philips’ exit

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy